You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LILRB4 STAR-T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • Chronic Myelomonocytic Leukemia
  • LILRB4 STAR-T cells injection
  • Tianjin, Tianjin, China
  • +1 more
Feb 12, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • LILRB4 STAR-T cells
  • (no location specified)
Sep 16, 2022

Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-hodgkin Lymphoma,B Cell
  • Autologous CD19-STAR-T cell
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

Trial (MSLN STAR-T cells)

Not yet recruiting
    • MSLN STAR-T cells
    • (no location specified)
    Apr 22, 2022

    B Cell Malignancy Trial in Sanhe (CD19-STAR-T cells)

    Completed
    • B Cell Malignancy
    • CD19-STAR-T cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Jan 28, 2022

    Refractory and Relapsed B Cell Acute Leukemia Trial in Sanhe (CD19/CD22-Dual-STAR-T)

    Suspended
    • Refractory and Relapsed B Cell Acute Leukemia
    • CD19/CD22-Dual-STAR-T
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Jan 29, 2022

    B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

    Recruiting
    • B Cell Malignancies
    • Universal CD19-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    Has Results
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

    Not yet recruiting
    • Head and Neck Cancer
    • +3 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Oct 18, 2023

    Psoriasis Trial in Sohag (skin biopsy)

    Not yet recruiting
    • Psoriasis
    • skin biopsy
    • Sohag, Egypt
      Sohag university Hospital
    Sep 21, 2023

    T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

    Recruiting
    • T-cell Lymphoma
    • T-cell Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Dec 16, 2022

    T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • +3 more
    • Universal CD7-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 17, 2023

    Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

    Recruiting
    • Metastatic Medullary Thyroid Cancer
    • single dose of CART-GFRa4 cells
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Sep 16, 2022

    Advanced Solid Tumor Trial in Shanghai (B4T2-001 Autologous CAR T cells)

    Recruiting
    • Advanced Solid Tumor
    • B4T2-001 Autologous CAR T cells
    • Shanghai, China/Shanghai, China
    • +1 more
    Nov 17, 2022

    T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)

    Terminated
    • T Cell Lymphoma
    • T-cell Leukemia
    • Efficacy of LCAR-T2C CAR-T cells
    • Beijing, Beijing, China
    • +1 more
    Aug 12, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Colorectal Cancer Metastatic Trial in Adelaide (CNA3103: 5 x 10^7 cells, CNA3103: 1.5 x 10^8 cells, CNA3103: 4.5 x 10^8 cells)

    Not yet recruiting
    • Colorectal Cancer Metastatic
    • CNA3103: 5 x 10^7 cells
    • +4 more
    • Adelaide, South Australia, Australia
      Carina Biotech Investigators
    Feb 26, 2023

    Interleukins in Periodontal Disease Progression

    Recruiting
    • Periodontitis
    • Gingivitis
    • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
    • Assiut, Asyut, Egypt
      Department of oral medicine, Periodontology, Oral diagnosis and
    Nov 16, 2023

    HIV-1 Infections Trial in Washington (HAART, T cells)

    Completed
    • HIV-1 Infections
    • Washington, District of Columbia
      Walter Reed Army Medical Center
    Aug 17, 2022

    Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)

    Recruiting
    • Autoimmune Diseases
    • 4SCAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Jul 17, 2022

    Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

    Recruiting
    • HIV-1-infection
    • Bioclinical evaluation
    • Nîmes, France
      CHU de Nimes
    Jul 28, 2022